Jim Cramer Calls Tandem Diabetes “Speculative Stock for Younger People”

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) is one of the stocks Jim Cramer shared insights on. Inquiring about the stock during the lightning round, a caller expressed that their son and grandson use products made by the company. Here’s what Cramer had to say in response:

“Alright, so… this is one of those, this is really difficult because I want to go with them, and the reason I want to go with them is they’re young. If they made a mistake, they got their whole life ahead of them. They’ve had the personal use of it. I looked at the company and said, jeez, I don’t like the fact that they keep losing money, but you know what? Let’s go with them and see what happens. Speculative stock for younger people, I actually encourage.”

Stock market data on a laptop screen. Photo by Alesia Kozik on Pexels

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) develops insulin delivery systems and digital health tools, infusion sets, cartridges, and platforms to support diabetes management.

While we acknowledge the risk and potential of TNDM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than TNDM and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.